- Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinomaLu B; Bao L B; Sun Z; Hua Z L; Wang X; Qu C PEuropean Review for Medical and Pharmacological Sciences, 2015, 19(19): 3605-3612.
- Is It Time for Maintenance Chemotherapy for Advanced Gastric Adenocarcinoma?Eren Orhan Onder; Sonmez Ozlem Uysal; Oyan BasakJournal of Clinical Oncology, 2016, 34(17): 2067.
- Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 studyMeulendijks Didier; de Groot Jan Willem B; Los Maartje; Boers James E; Beerepoot Laurens V; Polee Marco B; Beeker Aart; Portielje Johanna E A; Goey Swan H; de Jong Robert S; Vanhoutvin Steven A L W; Kuiper Maria; Sikorska Karolina; Pluim Dick; Beijnen Jos H; Schellens Jan H M; Grootscholten Cecile; Tesselaar Margot E T; Cats AnnemiekeCancer, 2016, 122(9): 1434-1443.
期刊论文
Safety, Feasibility, and Efficacy of Capecitabine Maintenance in Patients With Advanced Gastric Cancer: A Retrospective Study
16阅读
